See more : Sapmer SA (ALMER.PA) Income Statement Analysis – Financial Results
Complete financial analysis of American Vanguard Corporation (AVD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of American Vanguard Corporation, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- MDH Acquisition Corp. (MDH-WT) Income Statement Analysis – Financial Results
- Moriya Corporation (1798.T) Income Statement Analysis – Financial Results
- Medi Assist Health Ser L (MEDIASSIST.NS) Income Statement Analysis – Financial Results
- CITIC Resources Holdings Limited (1205.HK) Income Statement Analysis – Financial Results
- Grupo Financiero Inbursa, S.A.B. de C.V. (GPFOY) Income Statement Analysis – Financial Results
American Vanguard Corporation (AVD)
About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 579.37M | 609.62M | 556.87M | 458.70M | 468.19M | 454.27M | 355.05M | 312.11M | 289.38M | 298.63M | 381.02M | 366.19M | 304.43M | 229.62M | 209.33M | 237.54M | 216.66M | 193.77M | 189.80M | 150.86M | 124.86M | 100.67M | 87.02M | 77.98M | 69.21M | 67.00M | 67.70M | 48.60M | 55.40M | 45.10M | 45.50M | 38.70M | 29.30M | 22.30M | 19.00M | 17.90M | 18.90M | 15.90M |
Cost of Revenue | 400.21M | 368.26M | 343.63M | 286.11M | 290.83M | 271.64M | 207.66M | 183.83M | 177.48M | 184.14M | 209.67M | 205.07M | 181.36M | 140.54M | 148.90M | 136.41M | 120.93M | 111.41M | 104.12M | 78.60M | 65.99M | 56.80M | 45.20M | 38.46M | 32.73M | 36.80M | 37.60M | 26.00M | 27.30M | 21.90M | 20.90M | 17.80M | 14.30M | 12.70M | 10.10M | 10.20M | 10.70M | 9.00M |
Gross Profit | 179.16M | 241.35M | 213.24M | 172.59M | 177.35M | 182.63M | 147.39M | 128.29M | 111.90M | 114.50M | 171.35M | 161.13M | 123.07M | 89.08M | 60.43M | 101.13M | 95.73M | 82.36M | 85.68M | 72.26M | 58.87M | 43.88M | 41.82M | 39.52M | 36.48M | 30.20M | 30.10M | 22.60M | 28.10M | 23.20M | 24.60M | 20.90M | 15.00M | 9.60M | 8.90M | 7.70M | 8.20M | 6.90M |
Gross Profit Ratio | 30.92% | 39.59% | 38.29% | 37.63% | 37.88% | 40.20% | 41.51% | 41.10% | 38.67% | 38.34% | 44.97% | 44.00% | 40.43% | 38.80% | 28.87% | 42.57% | 44.18% | 42.50% | 45.14% | 47.90% | 47.15% | 43.58% | 48.06% | 50.68% | 52.70% | 45.07% | 44.46% | 46.50% | 50.72% | 51.44% | 54.07% | 54.01% | 51.19% | 43.05% | 46.84% | 43.02% | 43.39% | 43.40% |
Research & Development | 38.03M | 31.82M | 28.86M | 26.31M | 24.07M | 26.43M | 26.08M | 21.30M | 18.81M | 21.21M | 21.64M | 20.75M | 18.04M | 12.64M | 10.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 112.11M | 53.46M | 61.69M | 48.83M | 46.59M | 42.98M | 37.66M | 32.13M | 28.52M | 27.06M | 33.54M | 29.72M | 42.48M | 34.84M | 34.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 5.74M | 101.48M | 91.93M | 79.20M | 80.47M | 74.20M | 56.86M | 54.32M | 53.05M | 59.52M | 60.43M | 51.34M | 23.32M | 22.41M | 22.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 117.84M | 154.93M | 153.61M | 128.03M | 127.06M | 117.18M | 94.52M | 86.45M | 81.57M | 86.58M | 93.97M | 81.05M | 65.80M | 57.26M | 56.13M | 64.99M | 59.72M | 53.14M | 53.41M | 47.30M | 42.33M | 32.00M | 32.21M | 27.75M | 26.28M | 23.00M | 22.60M | 16.80M | 18.70M | 16.20M | 17.00M | 13.90M | 10.30M | 8.50M | 5.80M | 5.30M | 4.90M | 4.40M |
Other Expenses | 0.00 | 13.95M | 672.00K | -717.00K | 0.00 | 0.00 | 0.00 | 0.00 | -1.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -761.90K | 2.95M | 3.21M | 3.10M | 2.70M | 2.30M | 3.40M | 3.50M | 3.50M | 3.20M | 2.90M | 1.40M | 1.00M | 700.00K | 600.00K | 500.00K |
Operating Expenses | 155.87M | 200.70M | 182.47M | 153.62M | 151.13M | 143.61M | 120.60M | 107.75M | 100.38M | 107.79M | 115.61M | 101.80M | 83.84M | 69.89M | 66.76M | 64.99M | 59.72M | 53.14M | 53.41M | 47.30M | 42.33M | 32.00M | 31.45M | 30.69M | 29.50M | 26.10M | 25.30M | 19.10M | 22.10M | 19.70M | 20.50M | 17.10M | 13.20M | 9.90M | 6.80M | 6.00M | 5.50M | 4.90M |
Cost & Expenses | 556.08M | 568.96M | 526.10M | 439.74M | 441.97M | 415.25M | 328.25M | 291.57M | 277.86M | 291.92M | 325.29M | 306.87M | 265.20M | 210.43M | 215.66M | 201.39M | 180.65M | 164.56M | 157.53M | 125.90M | 108.32M | 88.79M | 76.65M | 69.15M | 62.23M | 62.90M | 62.90M | 45.10M | 49.40M | 41.60M | 41.40M | 34.90M | 27.50M | 22.60M | 16.90M | 16.20M | 16.20M | 13.90M |
Interest Income | 368.00K | 167.00K | 65.00K | 89.00K | 182.00K | 174.00K | 41.00K | 7.00K | 0.00 | 19.00K | 1.00K | 1.00K | 3.00K | 0.00 | 44.00K | 75.00K | 214.00K | 30.00K | 392.00K | 85.00K | 626.00K | 371.40K | 18.90K | 38.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 13.01M | 3.95M | 3.69M | 5.18M | 6.71M | 3.57M | 1.61M | 1.34M | 2.14M | 2.44M | 1.56M | 1.74M | 3.46M | 3.02M | 3.25M | 4.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 21.78M | 22.14M | 22.52M | 20.21M | 18.66M | 18.89M | 16.96M | 16.33M | 16.47M | 16.33M | 14.85M | 13.49M | 13.55M | 14.38M | 13.49M | 11.61M | 10.09M | 6.67M | 7.02M | 5.80M | 4.05M | 2.34M | 2.14M | 2.95M | 3.21M | 3.10M | 2.70M | 2.30M | 3.40M | 3.50M | 3.50M | 3.20M | 2.90M | 1.40M | 1.00M | 700.00K | 600.00K | 500.00K |
EBITDA | 45.08M | 66.36M | 53.41M | 38.87M | 48.85M | 62.56M | 48.97M | 36.87M | 27.93M | 22.46M | 69.87M | 72.09M | 52.23M | 19.19M | 7.16M | 47.83M | 46.10M | 35.89M | 39.28M | 30.76M | 20.60M | 14.22M | 12.51M | 11.78M | 10.19M | 7.20M | 7.50M | 5.80M | 9.40M | 7.00M | 7.60M | 7.00M | 4.70M | 1.10M | 3.10M | 2.40M | 3.30M | 2.50M |
EBITDA Ratio | 7.78% | 10.30% | 9.64% | 8.47% | 9.48% | 12.65% | 12.23% | 11.72% | 9.53% | 7.50% | 18.43% | 19.68% | 17.34% | 14.62% | 3.44% | 20.10% | 21.28% | 18.52% | 20.70% | 20.39% | 16.49% | 14.12% | 13.50% | 15.10% | 14.86% | 9.10% | 11.08% | 11.93% | 16.97% | 17.96% | 16.70% | 18.09% | 16.04% | 4.93% | 15.26% | 10.61% | 15.34% | 14.47% |
Operating Income | 23.30M | 40.65M | 30.95M | 23.63M | 26.22M | 39.02M | 26.79M | 20.54M | 11.52M | 6.71M | 55.74M | 59.32M | 39.23M | 19.19M | -6.33M | 36.14M | 36.01M | 29.22M | 32.27M | 24.96M | 16.54M | 11.88M | 10.37M | 8.83M | 6.98M | 4.10M | 4.80M | 3.50M | 6.00M | 3.50M | 4.10M | 3.80M | 1.80M | -300.00K | 2.10M | 1.70M | 2.70M | 2.00M |
Operating Income Ratio | 4.02% | 6.67% | 5.56% | 5.15% | 5.60% | 8.59% | 7.55% | 6.58% | 3.98% | 2.25% | 14.63% | 16.20% | 12.89% | 8.36% | -3.02% | 15.22% | 16.62% | 15.08% | 17.00% | 16.54% | 13.25% | 11.80% | 11.91% | 11.32% | 10.08% | 6.12% | 7.09% | 7.20% | 10.83% | 7.76% | 9.01% | 9.82% | 6.14% | -1.35% | 11.05% | 9.50% | 14.29% | 12.58% |
Total Other Income/Expenses | -13.00M | -4.69M | -3.81M | -5.18M | -7.21M | -5.43M | -1.94M | -1.62M | -2.56M | -3.07M | -1.90M | -2.47M | -4.00M | -3.02M | -3.21M | -3.97M | -5.49M | -2.69M | -1.33M | -1.23M | -360.00K | -602.00K | -1.34M | -1.43M | -1.76M | -900.00K | -1.50M | -900.00K | -1.00M | -2.00M | -800.00K | -800.00K | -1.30M | -700.00K | 0.00 | 400.00K | 100.00K | -100.00K |
Income Before Tax | 10.30M | 35.97M | 27.14M | 18.45M | 19.01M | 33.60M | 24.85M | 18.92M | 8.96M | 3.64M | 53.83M | 56.85M | 35.22M | 16.17M | -9.54M | 32.17M | 30.53M | 26.55M | 30.94M | 23.73M | 16.18M | 11.28M | 9.02M | 7.19M | 5.22M | 3.20M | 3.30M | 2.60M | 5.00M | 1.50M | 3.30M | 3.00M | 500.00K | -1.00M | 2.10M | 2.10M | 2.80M | 1.90M |
Income Before Tax Ratio | 1.78% | 5.90% | 4.87% | 4.02% | 4.06% | 7.40% | 7.00% | 6.06% | 3.10% | 1.22% | 14.13% | 15.53% | 11.57% | 7.04% | -4.56% | 13.54% | 14.09% | 13.70% | 16.30% | 15.73% | 12.96% | 11.20% | 10.37% | 9.21% | 7.55% | 4.78% | 4.87% | 5.35% | 9.03% | 3.33% | 7.25% | 7.75% | 1.71% | -4.48% | 11.05% | 11.73% | 14.81% | 11.95% |
Income Tax Expense | 2.78M | 8.56M | 8.17M | 3.08M | 5.20M | 9.15M | 4.44M | 5.54M | 2.01M | -451.00K | 18.92M | 20.03M | 13.16M | 5.19M | -3.75M | 12.15M | 11.80M | 11.07M | 11.94M | 9.26M | 5.92M | 4.23M | 3.38M | 2.87M | 1.99M | 1.10M | 1.30M | 1.00M | 1.90M | 300.00K | 1.10M | 1.10M | 200.00K | -100.00K | 800.00K | 700.00K | 1.20M | 900.00K |
Net Income | 7.52M | 27.40M | 18.59M | 15.24M | 13.60M | 24.20M | 20.27M | 12.79M | 6.59M | 4.84M | 34.45M | 36.87M | 22.07M | 10.98M | -5.79M | 20.02M | 18.73M | 15.45M | 19.00M | 14.48M | 10.26M | 7.05M | 5.64M | 4.31M | 3.24M | 2.10M | 2.00M | 1.60M | 3.10M | 1.20M | 2.20M | 1.90M | 300.00K | -900.00K | 1.40M | 1.40M | 1.60M | 1.00M |
Net Income Ratio | 1.30% | 4.50% | 3.34% | 3.32% | 2.91% | 5.33% | 5.71% | 4.10% | 2.28% | 1.62% | 9.04% | 10.07% | 7.25% | 4.78% | -2.77% | 8.43% | 8.64% | 7.97% | 10.01% | 9.60% | 8.22% | 7.00% | 6.48% | 5.53% | 4.67% | 3.13% | 2.95% | 3.29% | 5.60% | 2.66% | 4.84% | 4.91% | 1.02% | -4.04% | 7.37% | 7.82% | 8.47% | 6.29% |
EPS | 0.27 | 0.94 | 0.62 | 0.52 | 0.47 | 0.83 | 0.70 | 0.44 | 0.23 | 0.17 | 1.22 | 1.32 | 0.80 | 0.40 | -0.21 | 0.75 | 0.71 | 0.60 | 0.78 | 0.61 | 0.44 | 0.30 | 0.25 | 0.18 | 0.14 | 0.09 | 0.09 | 0.07 | 0.13 | 0.05 | 0.10 | 0.09 | 0.02 | -0.04 | 0.06 | 0.06 | 0.07 | 0.05 |
EPS Diluted | 0.26 | 0.92 | 0.61 | 0.51 | 0.46 | 0.81 | 0.68 | 0.44 | 0.23 | 0.17 | 1.19 | 1.28 | 0.79 | 0.40 | -0.21 | 0.73 | 0.68 | 0.57 | 0.74 | 0.57 | 0.41 | 0.29 | 0.24 | 0.18 | 0.14 | 0.09 | 0.09 | 0.07 | 0.13 | 0.05 | 0.10 | 0.09 | 0.02 | -0.04 | 0.06 | 0.06 | 0.07 | 0.05 |
Weighted Avg Shares Out | 28.13M | 29.23M | 29.81M | 29.45M | 29.03M | 29.33M | 29.10M | 28.86M | 28.67M | 28.44M | 28.30M | 27.91M | 27.56M | 27.39M | 27.12M | 26.64M | 26.31M | 25.93M | 24.34M | 23.95M | 23.50M | 23.12M | 22.95M | 23.67M | 23.96M | 24.22M | 20.04M | 23.94M | 24.65M | 22.30M | 21.71M | 22.33M | 18.44M | 23.20M | 22.38M | 22.38M | 21.67M | 21.03M |
Weighted Avg Shares Out (Dil) | 28.53M | 29.87M | 30.41M | 29.99M | 29.66M | 30.05M | 29.70M | 29.39M | 29.24M | 28.91M | 28.90M | 28.76M | 27.88M | 27.65M | 27.12M | 27.47M | 27.44M | 27.19M | 25.76M | 25.56M | 24.84M | 24.24M | 23.66M | 24.06M | 23.96M | 24.22M | 20.04M | 23.94M | 24.65M | 22.30M | 21.71M | 22.33M | 18.44M | 23.20M | 22.38M | 22.38M | 21.67M | 21.03M |
House panel subpoenas Vanguard, Arjuna in ESG 'collusion' probe
American Vanguard Hires Chief Transformation Officer
OHP®, an American Vanguard® Company, to Become Master Distributor of Certis® Biological Products in U.S. Non-crop Markets
American Vanguard Corporation (AVD) Q3 2023 Earnings Call Transcript
American Vanguard Reports Third Quarter and YTD 2023 Results
AMVAC® and NewLeaf Symbiotics® Extend North American Partnership to Key Global Markets
American Vanguard Announces New Senior VP of Human Resources
American Vanguard (AVD) Expands in Latin America With Punto Verde
American Vanguard Expands Latin American Presence by Acquiring Punto Verde in Ecuador
Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600
Source: https://incomestatements.info
Category: Stock Reports